Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.

L. Trodella, Lucio Trodella, R. M. D'Angelillo, Rolando Maria D'Angelillo, S. Ramella, Sara Ramella, F. Cellini, Numa Cellini, M. Ciresa, Marzia Ciresa, Alfredo Cesario, Pierluigi Granone

Research output: Contribution to journalArticle

5 Citations (Scopus)


Gemcitabine (2'-2'-difluorodeoxycytidine) is a well-known cytotoxic drug and a potent radio-enhancer. We herein report the in vitro evidence of its activity, and the clinical experiences when this drug is administered concurrently with radiation. The phase I-II trials are analyzed, focusing on the recent ability to deliver irradiation with low incidence of side effects.
Original languageEnglish
Pages (from-to)52-54
Number of pages3
JournalAnnals of Oncology
Publication statusPublished - 2006


  • lung cancer


Dive into the research topics of 'Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.'. Together they form a unique fingerprint.

Cite this